Results 41 to 50 of about 85 (50)

CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients. [PDF]

Cell Stress Chaperones, 2021
Hernandez-Cedeño M, Venegas-Rodriguez R, Peña-Ruiz R, Bequet-Romero M, Santana-Sanchez R, Penton-Arias E, Martinez-Donato G, Guillén-Nieto G, Dominguez-Horta MDC.   +8 more
europepmc   +1 more source

Clinical Phenotypes and Mortality Biomarkers: A Study Focused on COVID-19 Patients with Neurological Diseases in Intensive Care Units. [PDF]

Behav Sci (Basel), 2022
Morales Chacón LM, Galán García L, Cruz Hernández TM, Pavón Fuentes N, Maragoto Rizo C, Morales Suarez I, Morales Chacón O, Abad Molina E, Rocha Arrieta L.   +8 more
europepmc   +1 more source

The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases. [PDF]

J Neuroimmunol, 2021
Cama VF, Marín-Prida J, Acosta-Rivero N, Acosta EF, Díaz LO, Casadesús AV, Fernández-Marrero B, Gilva-Rodríguez N, Cremata-García D, Cervantes-Llanos M, Piniella-Matamoros B, Sánchez D, Del Rosario-Cruz L, Borrajero I, Díaz A, González Y, Pentón-Arias E, Montero-González T, Guillen-Nieto G, Pentón-Rol G.   +19 more
europepmc   +1 more source

Aportes del estudio de 800 autopsias de pacientes con la COVID-19 en Cuba

Revista Cubana de Medicina Militar
Introducción: En el año 2020 una nueva enfermedad se transformó en una pandemia. En Cuba se elaboró una metodología segura para su estudio morfológico.
José Domingo Hurtado de Mendoza Amat, Teresita Montero González , Virginia Capó de Paz , Laura López Marín , Licet González Fabián   +4 more
doaj  

Citrullinated peptides as drug candidates for rheumatoid arthritis. [PDF]

Front Immunol
Bustos AH, Brüner M, Kragstrup TW, Astakhova K.   +3 more
europepmc   +1 more source

Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities. [PDF]

Int J Mol Sci
Cho KH, Bahuguna A, Lee Y, Lee SH, Dominguez-Horta MDC, Martinez-Donato G.   +5 more
europepmc   +1 more source

Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (rHDL) against Acute Toxicity of Carboxymethyllysine in Zebrafish and Its Embryo. [PDF]

Pharmaceuticals (Basel)
Cho KH, Kim JE, Kang DJ, Dominguez-Horta MDC, Martinez-Donato G.   +4 more
europepmc   +1 more source

Molecular Chaperonin HSP60: Current Understanding and Future Prospects. [PDF]

Int J Mol Sci
Singh MK, Shin Y, Han S, Ha J, Tiwari PK, Kim SS, Kang I.   +6 more
europepmc   +1 more source

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match. [PDF]

BMJ Glob Health
Cokljat M, Cruz CV, Carrara VI, Puttaraksa K, Capriglioni C, Insaurralde SM, Rousseau-Portalis M, Roldan A, Watson JA, Tarning J, White NJ, Guerin PJ.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Caracterización de la unión entre Jusvinza y la Apolipoproteína A-I

Jusvinza es un fármaco inmunomodulador diseñado para el tratamiento de enfermedades autoinmunitarias. Este medicamento ha resultado eficaz en disminuir la inflamación de pacientes con Artritis Reumatoide (AR) y COVID-19 (del inglés Coronavirus Disease 2019) (Prada y col., 2018; Baldomero y col., 2020; Venegas y col., 2023).
openaire